• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immune regulation and control of regulatory T cells by OX40 and 4-1BB.OX40和4-1BB对调节性T细胞的免疫调节与控制
Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):253-62. doi: 10.1016/j.cytogfr.2008.04.003. Epub 2008 May 27.
2
Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses.OX40与4-1BB在调节效应性CD8 T细胞反应中的功能二分法。
J Immunol. 2006 Oct 1;177(7):4464-72. doi: 10.4049/jimmunol.177.7.4464.
3
During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.在呼吸道发生病毒感染期间,CD27、4-1BB和OX40共同决定CD8+记忆性T细胞的形成及其二次扩增能力。
J Immunol. 2005 Aug 1;175(3):1665-76. doi: 10.4049/jimmunol.175.3.1665.
4
4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.4-1BB和OX40独立发挥作用,以促进强大的CD8和CD4记忆反应。
J Immunol. 2004 Nov 15;173(10):5944-51. doi: 10.4049/jimmunol.173.10.5944.
5
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.双抗 OX40/IL-2 疗法通过 IL-2R 介导的 OX40 表达调控增强肿瘤免疫治疗。
PLoS One. 2012;7(4):e34467. doi: 10.1371/journal.pone.0034467. Epub 2012 Apr 4.
6
CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.共刺激分子CD134与CD137通路耦合,诱导产生超效应性CD8 T细胞,这些细胞随后变得依赖白细胞介素-7。
J Immunol. 2007 Aug 15;179(4):2203-14. doi: 10.4049/jimmunol.179.4.2203.
7
4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.4-1BB和OX40刺激增强CD8和CD4 T细胞对DNA初免、痘病毒加强疫苗的反应。
Immunology. 2004 Aug;112(4):559-66. doi: 10.1111/j.1365-2567.2004.01917.x.
8
The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells.OX40与4-1BB异二聚体在活化人T细胞中的表达及调控作用
Blood. 2005 Sep 15;106(6):2002-10. doi: 10.1182/blood-2004-04-1622. Epub 2005 Jun 7.
9
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.CD137/4-1BB 通路共刺激可保护人黑色素瘤肿瘤浸润淋巴细胞免于激活诱导的细胞死亡,并增强抗肿瘤效应功能。
J Immunother. 2011 Apr;34(3):236-50. doi: 10.1097/CJI.0b013e318209e7ec.
10
Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.肿瘤坏死因子受体超家族成员CD134(OX40)和CD137(4-1BB)的表达、共刺激作用及其在抗肿瘤免疫反应产生中的作用。
Eur J Immunol. 2002 Dec;32(12):3617-27. doi: 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M.

引用本文的文献

1
The role of tumor necrosis factor receptor superfamily in cancer: insights into oncogenesis, progression, and therapeutic strategies.肿瘤坏死因子受体超家族在癌症中的作用:对肿瘤发生、进展及治疗策略的见解
NPJ Precis Oncol. 2025 Aug 6;9(1):275. doi: 10.1038/s41698-025-00990-x.
2
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes.可激活T淋巴细胞上OX40的OX40配体融合蛋白的产生与特性分析
Front Immunol. 2025 Jan 10;15:1473815. doi: 10.3389/fimmu.2024.1473815. eCollection 2024.
3
Oncolytic vaccinia virus armed with 4-1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancreatic cancer model.携带4-1BBL的溶瘤痘苗病毒在胰腺癌模型中引发强大且安全的抗肿瘤免疫,并提高PD-1/PD-L1阻断疗法的治疗效果。
Transl Oncol. 2024 Dec;50:102151. doi: 10.1016/j.tranon.2024.102151. Epub 2024 Oct 9.
4
Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8 T cells in cis and in trans.人/鼠 CD137 激动剂 JNU-0921 通过增强顺式和反式 CD8 T 细胞的细胞毒性有效缩小肿瘤。
Sci Adv. 2024 Aug 23;10(34):eadp8647. doi: 10.1126/sciadv.adp8647.
5
Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets.单细胞转录组学表明,疟疾在多个免疫细胞亚群中促进了独特的调控反应。
Nat Commun. 2023 Nov 15;14(1):7387. doi: 10.1038/s41467-023-43181-7.
6
Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4 regulatory T cells.蛋白质组学揭示了人 TGF-β诱导和胸腺来源的 CD4 调节性 T 细胞的独特特征。
Sci Rep. 2022 Nov 24;12(1):20268. doi: 10.1038/s41598-022-23515-z.
7
Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?受体调节性 T 细胞:它们能否被利用以提高造血干细胞移植的成功率?
Front Immunol. 2022 Jun 21;13:932527. doi: 10.3389/fimmu.2022.932527. eCollection 2022.
8
Bone Morphogenetic Proteins Shape T Cells.骨形态发生蛋白塑造T细胞。
Front Immunol. 2022 Mar 28;13:865546. doi: 10.3389/fimmu.2022.865546. eCollection 2022.
9
Current Clinical Trial Landscape of OX40 Agonists.OX40 激动剂的当前临床试验格局。
Curr Oncol Rep. 2022 Jul;24(7):951-960. doi: 10.1007/s11912-022-01265-5. Epub 2022 Mar 29.
10
Blood-Brain Barrier, Cell Junctions, and Tumor Microenvironment in Brain Metastases, the Biological Prospects and Dilemma in Therapies.脑转移中的血脑屏障、细胞连接与肿瘤微环境,治疗中的生物学前景与困境
Front Cell Dev Biol. 2021 Aug 24;9:722917. doi: 10.3389/fcell.2021.722917. eCollection 2021.

本文引用的文献

1
4-1BB as a therapeutic target for human disease.4-1BB 作为人类疾病的治疗靶点。
Adv Exp Med Biol. 2009;647:120-9. doi: 10.1007/978-0-387-89520-8_8.
2
Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.基于白细胞介素-2与4-1BB信号协同作用的CD4+CD25+FoxP3+调节性T细胞的体外扩增
J Immunol. 2007 Dec 1;179(11):7295-304. doi: 10.4049/jimmunol.179.11.7295.
3
Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.辅助性T细胞1/2发育程序在外周诱导Foxp3 +调节性T细胞过程中的拮抗性质。
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18169-74. doi: 10.1073/pnas.0703642104. Epub 2007 Oct 31.
4
Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody.抗4-1BB单克隆抗体诱导的荷黑素瘤小鼠中CD11c+CD8+ T细胞显著扩增。
Mol Cells. 2007 Aug 31;24(1):132-8.
5
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.表达白细胞介素10的调节性T细胞在没有白细胞介素10的情况下由Foxp3 +和Foxp3-前体细胞发育而来。
Nat Immunol. 2007 Sep;8(9):931-41. doi: 10.1038/ni1504. Epub 2007 Aug 12.
6
Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells.前沿:OX40抑制转化生长因子β和抗原驱动的初始CD4 T细胞向CD25+Foxp3+ T细胞的转变。
J Immunol. 2007 Aug 1;179(3):1427-30. doi: 10.4049/jimmunol.179.3.1427.
7
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.在存在高水平共刺激的情况下,全反式维甲酸介导调节性T细胞的生长、分化增强及向肠道归巢。
J Exp Med. 2007 Aug 6;204(8):1765-74. doi: 10.1084/jem.20070719. Epub 2007 Jul 9.
8
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.小肠固有层树突状细胞通过视黄酸促进Foxp3调节性T细胞的从头生成。
J Exp Med. 2007 Aug 6;204(8):1775-85. doi: 10.1084/jem.20070602. Epub 2007 Jul 9.
9
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.一群功能特化的黏膜CD103⁺树突状细胞通过转化生长因子-β和视黄酸依赖机制诱导Foxp3⁺调节性T细胞。
J Exp Med. 2007 Aug 6;204(8):1757-64. doi: 10.1084/jem.20070590. Epub 2007 Jul 9.
10
CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.CREB/ATF依赖的T细胞受体诱导的FoxP3基因表达:DNA甲基化的作用
J Exp Med. 2007 Jul 9;204(7):1543-51. doi: 10.1084/jem.20070109. Epub 2007 Jun 25.

OX40和4-1BB对调节性T细胞的免疫调节与控制

Immune regulation and control of regulatory T cells by OX40 and 4-1BB.

作者信息

So Takanori, Lee Seung-Woo, Croft Michael

机构信息

Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.

出版信息

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):253-62. doi: 10.1016/j.cytogfr.2008.04.003. Epub 2008 May 27.

DOI:10.1016/j.cytogfr.2008.04.003
PMID:18508403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2486494/
Abstract

The TNFR family members OX40 (CD134) and 4-1BB (CD137) have been found to play major roles as costimulatory receptors for both CD4 and CD8 T cells. In particular, in many situations, they can control proliferation, survival, and cytokine production, and hence are thought to dictate accumulation of protective T cells during anti-viral and anti-tumor responses and pathogenic T cells during autoimmune reactions. As opposed to simply controlling the activity of naïve, effector, and memory T cells, recent data have suggested that both molecules are also instrumental in controlling the generation and activity of so-called regulatory or suppressor T cells (Treg), perhaps in both positive and negative manners. Part of the action on Treg might function to further promote protective or pathogenic T cells, but alternate activities of OX40 and 4-1BB on Treg are also being described that suggest that there might be control by these molecules at multiple levels that will alter the biological outcome when these receptors are ligated. This review specifically focuses on recent studies of regulatory T cells, and regulatory or suppressive activity, that are modulated by OX40 or 4-1BB.

摘要

肿瘤坏死因子受体(TNFR)家族成员OX40(CD134)和4-1BB(CD137)已被发现作为CD4和CD8 T细胞的共刺激受体发挥主要作用。特别是,在许多情况下,它们可以控制增殖、存活和细胞因子产生,因此被认为在抗病毒和抗肿瘤反应中决定保护性T细胞的积累,在自身免疫反应中决定致病性T细胞的积累。与简单地控制初始T细胞、效应T细胞和记忆T细胞的活性不同,最近的数据表明这两种分子在控制所谓的调节性或抑制性T细胞(Treg)的产生和活性方面也发挥着作用,可能是以正向和负向两种方式。对Treg的部分作用可能是进一步促进保护性或致病性T细胞,但也有关于OX40和4-1BB对Treg的其他活性的描述,这表明这些分子可能在多个水平上进行调控,当这些受体被激活时会改变生物学结果。本综述特别关注受OX40或4-1BB调节的调节性T细胞以及调节或抑制活性的最新研究。